A SARS-CoV-2 nanobody that can bind to the RBD region may be used for treatment in COVID-19 in animals

Coronavirus disease 2019 (COVID-19) caused by an infectious virus, severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), poses a threat to the world. The suitable treatments must be identified for this disease in animals. Nanobody have therapeutic potential in the COVID-19. In this study, SA...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Peng, Yang, Qin, Zhao, Xiaoli, Liu, Qingqing, Xi, Jing, Zhang, Fan, He, Jinke, Yang, Hang, Zhang, Chao, Ma, Zhongchen, Deng, Xiaoyu, Wang, Yong, Chen, Chuangfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821020/
https://www.ncbi.nlm.nih.gov/pubmed/35152188
http://dx.doi.org/10.1016/j.rvsc.2022.02.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821020/
https://www.ncbi.nlm.nih.gov/pubmed/35152188
http://dx.doi.org/10.1016/j.rvsc.2022.02.003

Ejemplares similares